A. Hoes

First name
A.
Middle name
W.
Last name
Hoes
van de Garde, E. M., Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M., & Leufkens, H. G. (2006). Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax. http://doi.org/10.1136/thx.2006.062885
Duijnhoven, R. G., Straus, S. M., Souverein, P. C., de Boer, A., Bosch, J. L., Hoes, A. W., & De Bruin, M. L. (2014). Long-term use of 5alpha-reductase inhibitors and the risk of male breast cancer. Cancer Causes Control. http://doi.org/10.1007/s10552-014-0455-6
Warnier, M. J., Rutten, F. H., Souverein, P. C., de Boer, A., Hoes, A. W., & De Bruin, M. L. (2015). Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3792
Tran-Duy, A., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., et al. (2018). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826
Gho, J., Schmidt, A. F., Pasea, L., Koudstaal, S., Pujades-Rodriguez, M., Denaxas, S., et al. (2018). An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors. BMJ Open. http://doi.org/10.1136/bmjopen-2017-018331
Tran-Duy, A., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., et al. (2019). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826
Uijl, A., Koudstaal, S., Direk, K., Denaxas, S., Groenwold, R. H. H., Banerjee, A., et al. (2019). Risk factors for incident heart failure in age- and sex-specific strata: a population-based cohort using linked electronic health records. Eur J Heart Fail. http://doi.org/10.1002/ejhf.1350
van den Dries, C. J., van Doorn, S., Souverein, P., Pajouheshnia, R., Moons, K. G. M., Hoes, A. W., et al. (2020). The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation. TH Open. http://doi.org/10.1055/s-0040-1721499